Treatment of streptococcal pharyngitis. I. Clinical evaluation.
A study was undertaken to evaluate the therapy of streptococcal pharyngitis. The compliance of 118 patients with beta-hemolytic streptococcal pharyngitis to follow-up was 72%. Of 74 patients checked by means of urine tests 66 took their oral medication. No differences were detected in the clinical and bacteriological results (>98% streptococcal eradication) after the 7th or 10th day of therapy after taking either cephalexin or penicillin.IT WAS CONCLUDED THAT: (a) for effective surveillance and follow-up special attention should be given to the uncooperative segment of the patient population; (b) a seven-day course of penicillin may be satisfactory in the eradication of BHS from the throat; and (c) cephalexin appears to be an effective alternative to penicillin for the treatment of streptococcal pharyngitis.
D000553:Ambulatory Care; D001294:Attitude to Health; D002170:Canada; D002506:Cephalexin / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D005500:Follow-Up Studies; D006801:Humans; D008826:Microbial Sensitivity Tests; D010400:Penicillin G / Q000627:therapeutic use*; D010612:Pharyngitis / Q000188:drug therapy*; D010614:Pharynx / Q000382:microbiology; D011159:Population Surveillance; D013290:Streptococcal Infections / Q000188:drug therapy*
D002506:Cephalexin; D010400:Penicillin G